Sanne de Wit - Publications

Affiliations: 
University of Amsterdam, Amsterdam, Netherlands 

22/306 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 van Timmeren T, O'Doherty JP, Dzinalija N, de Wit S. Can the Brain Strategically Go on Automatic Pilot? A Functional Magnetic Resonance Imaging Study Investigating the Effect of If-Then Planning on Behavioral Flexibility. Journal of Cognitive Neuroscience. 1-19. PMID 36976901 DOI: 10.1162/jocn_a_01990  0.322
2023 Berner LA, Fiore VG, Chen JY, Krueger A, Kaye WH, Viranda T, de Wit S. Impaired belief updating and devaluation in adult women with bulimia nervosa. Translational Psychiatry. 13: 2. PMID 36604416 DOI: 10.1038/s41398-022-02257-6  0.401
2022 van Timmeren T, de Wit S. Instant habits versus flexible tenacity: Do implementation intentions accelerate habit formation? Quarterly Journal of Experimental Psychology (2006). 17470218221147024. PMID 36476147 DOI: 10.1177/17470218221147024  0.366
2018 Watson P, van Wingen G, de Wit S. Conflicted between Goal-Directed and Habitual Control, an fMRI Investigation. Eneuro. 5. PMID 30310863 DOI: 10.1523/ENEURO.0240-18.2018  0.425
2018 de Wit S, Kindt M, Knot SL, Verhoeven AAC, Robbins TW, Gasull-Camos J, Evans M, Mirza H, Gillan CM. Shifting the balance between goals and habits: Five failures in experimental habit induction. Journal of Experimental Psychology. General. 147: 1043-1065. PMID 29975092 DOI: 10.1037/Xge0000402  0.375
2017 Verhoeven AAC, Kindt M, Zomer CL, de Wit S. An experimental investigation of breaking learnt habits with verbal implementation intentions. Acta Psychologica. PMID 28552168 DOI: 10.1016/J.Actpsy.2017.05.008  0.377
2016 Sjoerds Z, Dietrich A, Deserno L, de Wit S, Villringer A, Heinze HJ, Schlagenhauf F, Horstmann A. Slips of Action and Sequential Decisions: A Cross-Validation Study of Tasks Assessing Habitual and Goal-Directed Action Control. Frontiers in Behavioral Neuroscience. 10: 234. PMID 28066200 DOI: 10.3389/Fnbeh.2016.00234  0.661
2016 Godier LR, de Wit S, Pinto A, Steinglass JE, Greene AL, Scaife J, Gillan CM, Walsh BT, Simpson HB, Park RJ. An investigation of habit learning in Anorexia Nervosa. Psychiatry Research. 244: 214-222. PMID 27497292 DOI: 10.1016/J.Psychres.2016.07.051  0.303
2015 Delorme C, Salvador A, Valabrègue R, Roze E, Palminteri S, Vidailhet M, de Wit S, Robbins T, Hartmann A, Worbe Y. Enhanced habit formation in Gilles de la Tourette syndrome. Brain : a Journal of Neurology. PMID 26490329 DOI: 10.1093/Brain/Awv307  0.313
2015 Watson P, van Steenbergen H, de Wit S, Wiers RW, Hommel B. Limits of ideomotor action-outcome acquisition. Brain Research. PMID 25704203 DOI: 10.1016/j.brainres.2015.02.020  0.31
2014 de Wit S, van de Vijver I, Ridderinkhof KR. Impaired acquisition of goal-directed action in healthy aging. Cognitive, Affective & Behavioral Neuroscience. 14: 647-58. PMID 24796599 DOI: 10.3758/s13415-014-0288-5  0.309
2014 Geurts HM, de Wit S. Goal-directed action control in children with autism spectrum disorders. Autism : the International Journal of Research and Practice. 18: 409-18. PMID 24072663 DOI: 10.1177/1362361313477919  0.301
2013 Sjoerds Z, de Wit S, van den Brink W, Robbins TW, Beekman AT, Penninx BW, Veltman DJ. Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients. Translational Psychiatry. 3: e337. PMID 24346135 DOI: 10.1038/Tp.2013.107  0.658
2013 de Wit S, Ridderinkhof KR, Fletcher PC, Dickinson A. Resolution of outcome-induced response conflict by humans after extended training. Psychological Research. 77: 780-93. PMID 23192433 DOI: 10.1007/s00426-012-0467-3  0.611
2011 de Wit S, Barker RA, Dickinson AD, Cools R. Habitual versus goal-directed action control in Parkinson disease. Journal of Cognitive Neuroscience. 23: 1218-29. PMID 20429859 DOI: 10.1162/jocn.2010.21514  0.57
2009 de Wit S, Corlett PR, Aitken MR, Dickinson A, Fletcher PC. Differential engagement of the ventromedial prefrontal cortex by goal-directed and habitual behavior toward food pictures in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 11330-8. PMID 19741139 DOI: 10.1523/Jneurosci.1639-09.2009  0.646
2009 de Wit S, Ostlund SB, Balleine BW, Dickinson A. Resolution of conflict between goal-directed actions: outcome encoding and neural control processes. Journal of Experimental Psychology. Animal Behavior Processes. 35: 382-93. PMID 19594283 DOI: 10.1037/A0014793  0.691
2009 de Wit S, Dickinson A. Associative theories of goal-directed behaviour: a case for animal-human translational models. Psychological Research. 73: 463-76. PMID 19350272 DOI: 10.1007/s00426-009-0230-6  0.593
2007 de Wit S, Niry D, Wariyar R, Aitken MR, Dickinson A. Stimulus-outcome interactions during instrumental discrimination learning by rats and humans. Journal of Experimental Psychology. Animal Behavior Processes. 33: 1-11. PMID 17227190 DOI: 10.1037/0097-7403.33.1.1  0.615
2006 de Wit S, Kosaki Y, Balleine BW, Dickinson A. Dorsomedial prefrontal cortex resolves response conflict in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 5224-9. PMID 16687514 DOI: 10.1523/Jneurosci.5175-05.2006  0.664
2003 Dickinson A, de Wit S. The interaction between discriminative stimuli and outcomes during instrumental learning. The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology. 56: 127-39. PMID 12623543 DOI: 10.1080/02724990244000223  0.584
2002 Mineur YS, Sluyter F, de Wit S, Oostra BA, Crusio WE. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus. 12: 39-46. PMID 11918286 DOI: 10.1002/hipo.10005  0.527
Low-probability matches (unlikely to be authored by this person)
2017 van Steenbergen H, Watson P, Wiers RW, Hommel B, de Wit S. Dissociable corticostriatal circuits underlie goal-directed versus cue-elicited habitual food seeking after satiation: Evidence from a multimodal MRI study. The European Journal of Neuroscience. PMID 28444823 DOI: 10.1111/ejn.13586  0.293
2015 van de Vijver I, Ridderinkhof KR, de Wit S. Age-related changes in deterministic learning from positive versus negative performance feedback. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 22: 595-619. PMID 25761598 DOI: 10.1080/13825585.2015.1020917  0.272
2012 de Wit S, Watson P, Harsay HA, Cohen MX, van de Vijver I, Ridderinkhof KR. Corticostriatal connectivity underlies individual differences in the balance between habitual and goal-directed action control. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 12066-75. PMID 22933790 DOI: 10.1523/JNEUROSCI.1088-12.2012  0.266
2012 Watson P, de Wit S, Hommel B, Wiers RW. Motivational Mechanisms and Outcome Expectancies Underlying the Approach Bias toward Addictive Substances. Frontiers in Psychology. 3: 440. PMID 23133434 DOI: 10.3389/fpsyg.2012.00440  0.259
2010 Fletcher PC, Napolitano A, Skeggs A, Miller SR, Delafont B, Cambridge VC, de Wit S, Nathan PJ, Brooke A, O'Rahilly S, Farooqi IS, Bullmore ET. Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 14346-55. PMID 20980590 DOI: 10.1523/Jneurosci.3323-10.2010  0.253
2021 Ibáñez de Aldecoa P, de Wit S, Tebbich S. Can Habits Impede Creativity by Inducing Fixation? Frontiers in Psychology. 12: 683024. PMID 34721137 DOI: 10.3389/fpsyg.2021.683024  0.247
2017 Verhoeven AAC, Watson P, de Wit S. Failing to pay heed to health warnings in a food-associated environment. Appetite. PMID 29054742 DOI: 10.1016/j.appet.2017.10.020  0.247
2018 Linnebank FE, Kindt M, de Wit S. Investigating the balance between goal-directed and habitual control in experimental and real-life settings. Learning & Behavior. PMID 29426981 DOI: 10.3758/S13420-018-0313-6  0.245
2017 van Steenbergen H, Warren CM, Kühn S, de Wit S, Wiers RW, Hommel B. Representational precision in visual cortex reveals outcome encoding and reward modulation during action preparation. Neuroimage. PMID 28619654 DOI: 10.1016/j.neuroimage.2017.06.012  0.243
2023 van de Vijver I, Verhoeven AAC, de Wit S. Individual Differences in Corticostriatal White-matter Tracts Predict Successful Daily-life Routine Formation. Journal of Cognitive Neuroscience. 1-17. PMID 36724394 DOI: 10.1162/jocn_a_01967  0.232
2013 Vriend C, de Wit SJ, Remijnse PL, van Balkom AJ, Veltman DJ, van den Heuvel OA. Switch the itch: a naturalistic follow-up study on the neural correlates of cognitive flexibility in obsessive-compulsive disorder. Psychiatry Research. 213: 31-8. PMID 23693090 DOI: 10.1016/J.Pscychresns.2012.12.006  0.229
2013 O'Callaghan C, Moustafa AA, de Wit S, Shine JM, Robbins TW, Lewis SJ, Hornberger M. Fronto-striatal gray matter contributions to discrimination learning in Parkinson's disease. Frontiers in Computational Neuroscience. 7: 180. PMID 24376416 DOI: 10.3389/Fncom.2013.00180  0.227
2012 de Wit SJ, de Vries FE, van der Werf YD, Cath DC, Heslenfeld DJ, Veltman EM, van Balkom AJ, Veltman DJ, van den Heuvel OA. Presupplementary motor area hyperactivity during response inhibition: a candidate endophenotype of obsessive-compulsive disorder. The American Journal of Psychiatry. 169: 1100-8. PMID 23032388 DOI: 10.1176/Appi.Ajp.2012.12010073  0.222
2016 Snorrason I, Lee HJ, de Wit S, Woods DW. Are nonclinical obsessive-compulsive symptoms associated with bias toward habits? Psychiatry Research. 241: 221-223. PMID 27183107 DOI: 10.1016/j.psychres.2016.04.067  0.218
2012 de Wit S, Standing HR, Devito EE, Robinson OJ, Ridderinkhof KR, Robbins TW, Sahakian BJ. Reliance on habits at the expense of goal-directed control following dopamine precursor depletion. Psychopharmacology. 219: 621-31. PMID 22134475 DOI: 10.1007/s00213-011-2563-2  0.216
2018 Watson P, Wiers RW, Hommel B, de Wit S. Motivational sensitivity of outcome-response priming: Experimental research and theoretical models. Psychonomic Bulletin & Review. PMID 29468416 DOI: 10.3758/s13423-018-1449-2  0.215
2011 Gillan CM, Papmeyer M, Morein-Zamir S, Sahakian BJ, Fineberg NA, Robbins TW, de Wit S. Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. The American Journal of Psychiatry. 168: 718-26. PMID 21572165 DOI: 10.1176/Appi.Ajp.2011.10071062  0.215
2015 Worbe Y, Savulich G, de Wit S, Fernandez-Egea E, Robbins TW. Tryptophan Depletion Promotes Habitual over Goal-Directed Control of Appetitive Responding in Humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 25663044 DOI: 10.1093/Ijnp/Pyv013  0.209
2014 Watson P, Wiers RW, Hommel B, de Wit S. Working for food you don't desire. Cues interfere with goal-directed food-seeking. Appetite. 79: 139-48. PMID 24743030 DOI: 10.1016/j.appet.2014.04.005  0.208
2015 Watson P, Wiers RW, Hommel B, Ridderinkhof KR, de Wit S. An associative account of how the obesogenic environment biases adolescents' food choices. Appetite. PMID 26482282 DOI: 10.1016/j.appet.2015.10.008  0.202
2019 Luijten M, Gillan CM, De Wit S, Franken IHA, Robbins TW, Ersche KD. Goal-Directed and Habitual Control in Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 30768206 DOI: 10.1093/Ntr/Ntz001  0.193
2016 Dietrich A, de Wit S, Horstmann A. General Habit Propensity Relates to the Sensation Seeking Subdomain of Impulsivity But Not Obesity. Frontiers in Behavioral Neuroscience. 10: 213. PMID 27877117 DOI: 10.3389/Fnbeh.2016.00213  0.178
2017 Watson P, Wiers RW, Hommel B, Gerdes VEA, de Wit S. Stimulus Control Over Action for Food in Obese versus Healthy-weight Individuals. Frontiers in Psychology. 8: 580. PMID 28450844 DOI: 10.3389/fpsyg.2017.00580  0.178
2016 Ersche KD, Gillan CM, Jones PS, Williams GB, Ward LH, Luijten M, de Wit S, Sahakian BJ, Bullmore ET, Robbins TW. Carrots and sticks fail to change behavior in cocaine addiction. Science (New York, N.Y.). 352: 1468-71. PMID 27313048 DOI: 10.1126/Science.Aaf3700  0.178
2014 van Velzen LS, Vriend C, de Wit SJ, van den Heuvel OA. Response inhibition and interference control in obsessive-compulsive spectrum disorders. Frontiers in Human Neuroscience. 8: 419. PMID 24966828 DOI: 10.3389/Fnhum.2014.00419  0.172
2015 van Velzen LS, de Wit SJ, Ćurĉić-Blake B, Cath DC, de Vries FE, Veltman DJ, van der Werf YD, van den Heuvel OA. Altered inhibition-related frontolimbic connectivity in obsessive-compulsive disorder. Human Brain Mapping. 36: 4064-75. PMID 26183689 DOI: 10.1002/Hbm.22898  0.167
2016 de Wit S, Ziermans TB, Nieuwenhuis M, Schothorst PF, van Engeland H, Kahn RS, Durston S, Schnack HG. Individual prediction of long-term outcome in adolescents at ultra-high risk for psychosis: Applying machine learning techniques to brain imaging data. Human Brain Mapping. PMID 27699911 DOI: 10.1002/Hbm.23410  0.164
2014 Ziermans T, de Wit S, Schothorst P, Sprong M, van Engeland H, Kahn R, Durston S. Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up. Plos One. 9: e93994. PMID 24705808 DOI: 10.1371/Journal.Pone.0093994  0.162
2022 Brinkhof LP, Ridderinkhof KR, van de Vijver I, Murre JMJ, Krugers HJ, de Wit S. Psychological Coping and Behavioral Adjustment Among Older Adults in Times of COVID-19: Exploring the Protective Role of Working Memory and Habit Propensity. Journal of Adult Development. 1-15. PMID 35637691 DOI: 10.1007/s10804-022-09404-9  0.161
2023 Brinkhof LP, Ridderinkhof KR, Murre JMJ, Krugers HJ, de Wit S. Improving goal striving and resilience in older adults through a personalized metacognitive self-help intervention: a protocol paper. Bmc Psychology. 11: 223. PMID 37542308 DOI: 10.1186/s40359-023-01259-3  0.157
2021 Frank-Podlech S, Watson P, Verhoeven AAC, Stegmaier S, Preissl H, de Wit S. Competing influences on healthy food choices: Mindsetting versus contextual food cues. Appetite. 166: 105476. PMID 34174362 DOI: 10.1016/j.appet.2021.105476  0.152
2014 de Wit SJ, Alonso P, Schweren L, Mataix-Cols D, Lochner C, Menchón JM, Stein DJ, Fouche JP, Soriano-Mas C, Sato JR, Hoexter MQ, Denys D, Nakamae T, Nishida S, Kwon JS, et al. Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. The American Journal of Psychiatry. 171: 340-9. PMID 24220667 DOI: 10.1176/Appi.Ajp.2013.13040574  0.148
2018 Gottwald J, de Wit S, Apergis-Schoute AM, Morein-Zamir S, Kaser M, Cormack F, Sule A, Limmer W, Morris AC, Robbins TW, Sahakian BJ. Impaired cognitive plasticity and goal-directed control in adolescent obsessive-compulsive disorder. Psychological Medicine. 1-9. PMID 29353562 DOI: 10.1017/S0033291717003464  0.144
2011 Moore JW, Turner DC, Corlett PR, Arana FS, Morgan HL, Absalom AR, Adapa R, de Wit S, Everitt JC, Gardner JM, Pigott JS, Haggard P, Fletcher PC. Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia. Cognitive Neuropsychiatry. 16: 364-81. PMID 21302161 DOI: 10.1080/13546805.2010.546074  0.126
2015 Achhra AC, Phillips A, Emery S, MacArthur RD, Furrer H, De Wit S, Losso M, Law MG. Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy. Hiv Medicine. 16: 449-54. PMID 25959989 DOI: 10.1111/hiv.12258  0.124
2024 de Wit S, Geerlings L, Shi C, Dronkers J, Schouten EM, Blancke G, Andries V, Yntema T, Meijers WC, Koonen DPY, Vereecke L, Silljé HHW, Aboumsallem JP, de Boer RA. Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice. Cardiovascular Research. PMID 38400709 DOI: 10.1093/cvr/cvae038  0.12
2023 Brinkhof LP, de Wit S, Murre JMJ, Ridderinkhof KR. Mitigating the Harmful Impact of Ageism among Older Individuals: The Buffering Role of Resilience Factors. Geriatrics (Basel, Switzerland). 9. PMID 38392100 DOI: 10.3390/geriatrics9010001  0.12
2004 Derdelinckx I, Van Laethem K, Maes B, Schrooten Y, De Wit S, Florence E, Fransen K, Ribas SG, Marissens D, Moutschen M, Vaira D, Zissis G, Van Ranst M, Van Wijngaerden E, Vandamme AM. Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response. Journal of Acquired Immune Deficiency Syndromes (1999). 37: 1664-6. PMID 15577426  0.119
1997 Payen MC, De Wit S, Sommereijns B, Clumeck N. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS. Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 51: 439-45. PMID 9863502  0.118
2012 De Wit SJ. Presupplementary motor area hyperactivity during response inhibition: A candidate endophenotype of obsessive-compulsive disorder (American Journal of Psychiatry (2012) 169, (1100-1108) American Journal of Psychiatry. 169: 1218. DOI: 10.1176/appi.ajp.2012.16911correction  0.115
2012 Castagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, et al. Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. The Lancet. Infectious Diseases. 12: 119-27. PMID 21988895 DOI: 10.1016/S1473-3099(11)70248-1  0.115
2011 Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study. Journal of the International Aids Society. 14: 16. PMID 21443771 DOI: 10.1186/1758-2652-14-16  0.113
2014 Megens S, De Wit S, Bernatchez J, Dekeersmaeker N, Vinken L, Covens K, Theys K, Camacho RJ, Vandamme AM, Götte M, Van Laethem K. Characterization of amino acids Arg, Ser and Thr at position 70 within HIV-1 reverse transcriptase. Acta Clinica Belgica. 69: 348-57. PMID 25103592 DOI: 10.1179/2295333714Y.0000000038  0.112
2013 Sabin CA, Ryom L, Kovari H, Kirk O, de Wit S, Law M, Reiss P, Dabis F, Pradier C, El-Sadr W, Monforte Ad, Kamara D, Phillips AN, Lundgren JD. Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D study. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 456-63. PMID 23535291 DOI: 10.1097/QAI.0b013e318291cd29  0.112
2018 Zeune LL, de Wit S, Berghuis AMS, IJzerman MJ, Terstappen LWMM, Brune C. How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 30246927 DOI: 10.1002/cyto.a.23576  0.111
2019 Tamminga M, de Wit S, Schuuring E, Timens W, Terstappen LWMM, Hiltermann TJN, Groen HJM. Circulating tumor cells in lung cancer are prognostic and predictive for worse tumor response in both targeted- and chemotherapy. Translational Lung Cancer Research. 8: 854-861. PMID 32010564 DOI: 10.21037/tlcr.2019.11.06  0.11
2005 Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. Aids (London, England). 19: 593-601. PMID 15802978  0.108
2014 de Wit S, Schothorst PF, Oranje B, Ziermans TB, Durston S, Kahn RS. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 865-73. PMID 24636460 DOI: 10.1016/J.Euroneuro.2014.02.008  0.105
2021 Brinkhof LP, Huth KBS, Murre JMJ, de Wit S, Krugers HJ, Ridderinkhof KR. The Interplay Between Quality of Life and Resilience Factors in Later Life: A Network Analysis. Frontiers in Psychology. 12: 752564. PMID 34867644 DOI: 10.3389/fpsyg.2021.752564  0.104
2015 Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait-Ammar A, Delacourt N, Melard A, Kabeya K, Vanhulle C, Van Driessche B, Gatot JS, Cherrier T, Pianowski LF, Gama L, ... ... De Wit S, et al. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression. Plos Pathogens. 11: e1005063. PMID 26225566 DOI: 10.1371/Journal.Ppat.1005063  0.104
2021 Blanken TF, Tanis CC, Nauta FH, Dablander F, Zijlstra BJH, Bouten RRM, Oostvogel QH, Boersma MJ, van der Steenhoven MV, van Harreveld F, de Wit S, Borsboom D. Promoting physical distancing during COVID-19: a systematic approach to compare behavioral interventions. Scientific Reports. 11: 19463. PMID 34593931 DOI: 10.1038/s41598-021-98964-z  0.099
2011 Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, Neaton JD. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 56: 36-43. PMID 20930640 DOI: 10.1097/Qai.0B013E3181F7F61A  0.095
2023 van de Vijver I, Brinkhof LP, de Wit S. Age differences in routine formation: the role of automatization, motivation, and executive functions. Frontiers in Psychology. 14: 1140366. PMID 37484115 DOI: 10.3389/fpsyg.2023.1140366  0.093
2021 van der Schoor LWE, Verkade HJ, Bertolini A, de Wit S, Mennillo E, Rettenmeier E, Weber AA, Havinga R, Valášková P, Jašprová J, Struik D, Bloks VW, Chen S, Schreuder AB, Vítek L, et al. Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia. Scientific Reports. 11: 11107. PMID 34045606 DOI: 10.1038/s41598-021-90687-5  0.093
2010 Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups On Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 17: 491-501. PMID 20543702 DOI: 10.1097/Hjr.0B013E328336A150  0.093
2008 Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. Plos Medicine. 5: e203. PMID 18942885 DOI: 10.1371/Journal.Pmed.0050203  0.093
2014 de Vries FE, de Wit SJ, Cath DC, van der Werf YD, van der Borden V, van Rossum TB, van Balkom AJ, van der Wee NJ, Veltman DJ, van den Heuvel OA. Compensatory frontoparietal activity during working memory: an endophenotype of obsessive-compulsive disorder. Biological Psychiatry. 76: 878-87. PMID 24365484 DOI: 10.1016/J.Biopsych.2013.11.021  0.091
2012 Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon D, Paton NI, Prineas RJ, Neaton JD. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. Plos One. 7: e44454. PMID 22970224 DOI: 10.1371/journal.pone.0044454  0.091
2006 Law MG, Friis-Møller N, El-Sadr WM, Weber R, Reiss P, D'Arminio Monforte A, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Kirk O, Sabin CA, Phillips AN, Lundgren JD, et al. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. Hiv Medicine. 7: 218-30. PMID 16630034 DOI: 10.1111/J.1468-1293.2006.00362.X  0.089
2011 Mocroft A, Lifson AR, Touloumi G, Neuhaus J, Fox Z, Palfreeman A, Vjecha MJ, Hodder S, De Wit S, Lundgren JD, Phillips AN. Haemoglobin and anaemia in the SMART study. Antiviral Therapy. 16: 329-37. PMID 21555815 DOI: 10.1186/1758-2652-13-S4-P144  0.089
2004 De Wit S, Boulmé R, Poll B, Schmit JC, Clumeck N. Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients. Aids (London, England). 18: 2330-1. PMID 15577548  0.088
2010 van den Heuvel OA, van der Werf YD, Verhoef KM, de Wit S, Berendse HW, Wolters ECh, Veltman DJ, Groenewegen HJ. Frontal-striatal abnormalities underlying behaviours in the compulsive-impulsive spectrum. Journal of the Neurological Sciences. 289: 55-9. PMID 19729172 DOI: 10.1016/J.Jns.2009.08.043  0.088
2012 Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. International Journal of Epidemiology. 41: 433-45. PMID 22493325 DOI: 10.1093/ije/dyr164  0.085
2022 Brinkhof LP, Ridderinkhof KR, Krugers HJ, Murre JMJ, de Wit S. Assessing the degree of urbanisation using a single-item self-report measure: a validation study. International Journal of Environmental Health Research. 1-10. PMID 35180828 DOI: 10.1080/09603123.2022.2036331  0.085
2009 Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte Ad, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N. Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study. Diabetes Care. 32: 474-80. PMID 19056612 DOI: 10.2337/Dc08-1394  0.084
2011 De Wit S, Delforge M, Necsoi CV, Clumeck N. Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load. Aids (London, England). 25: 1332-3. PMID 21508802 DOI: 10.1097/QAD.0b013e328347c083  0.083
2011 Vandamme AM, Camacho RJ, Ceccherini-Silberstein F, De Luca A, Palmisano L, Paraskevis D, Paredes R, Poljak M, Schmit JC, Soriano V, Walter H, Sönnerborg A, Ait-Khaled M, Albert J, Åsjö B, ... ... De Wit S, et al. European recommendations for the clinical use of HIV drug resistance testing: 2011 update Aids Reviews. 13: 77-108. PMID 21587341  0.083
2014 Béténé A Dooko C, De Wit S, Neuhaus J, Palfreeman A, Pepe R, Pankow JS, Neaton JD. Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 538-46. PMID 25393940 DOI: 10.1097/Qai.0000000000000354  0.083
2008 Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Deforche K, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, et al. Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. Aids Research and Human Retroviruses. 24: 355-62. PMID 18327983 DOI: 10.1089/aid.2007.0212  0.081
2022 Brinkhof LP, de Wit S, Murre JMJ, Krugers HJ, Ridderinkhof KR. The Subjective Experience of Ageism: The Perceived Ageism Questionnaire (PAQ). International Journal of Environmental Research and Public Health. 19. PMID 35886644 DOI: 10.3390/ijerph19148792  0.081
2012 Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyand M, Reiss P, El-Sadr W, Monforte AD, Friis-Møller N, Lundgren JD, Law MG. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Journal of the International Aids Society. 15: 17426. PMID 23078769 DOI: 10.7448/IAS.15.2.17426  0.081
2015 Nkuize M, De Wit S, Muls V, Pirenne C, Buset M. The role of upper gastrointestinal endoscopy in the era of modern antiretroviral therapy. European Journal of Gastroenterology & Hepatology. 27: 1459-65. PMID 26352131 DOI: 10.1097/MEG.0000000000000467  0.081
2009 Reuse S, Calao M, Kabeya K, Guiguen A, Gatot JS, Quivy V, Vanhulle C, Lamine A, Vaira D, Demonte D, Martinelli V, Veithen E, Cherrier T, Avettand V, Poutrel S, ... ... De Wit S, et al. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. Plos One. 4: e6093. PMID 19564922 DOI: 10.1371/journal.pone.0006093  0.081
2013 Melief J, de Wit SJ, van Eden CG, Teunissen C, Hamann J, Uitdehaag BM, Swaab D, Huitinga I. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter. Acta Neuropathologica. 126: 237-49. PMID 23812288 DOI: 10.1007/s00401-013-1140-7  0.08
2014 Freidl GS, de Bruin E, van Beek J, Reimerink J, de Wit S, Koch G, Vervelde L, van den Ham HJ, Koopmans MP. Getting more out of less--a quantitative serological screening tool for simultaneous detection of multiple influenza A hemagglutinin-types in chickens. Plos One. 9: e108043. PMID 25248105 DOI: 10.1371/journal.pone.0108043  0.08
2016 de Wit S, Wierenga LM, Oranje B, Ziermans TB, Schothorst PF, van Engeland H, Kahn RS, Durston S. Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience. Neuroimage. Clinical. 12: 542-549. PMID 27672558 DOI: 10.1016/J.Nicl.2016.08.013  0.08
2014 Kalf JG, de Wit S. Orofaryngeale slikstoornissen bij neurodegeneratieve aandoeningen. Tijdschrift Voor Gerontologie En Geriatrie. 45: 273-81. PMID 25253555 DOI: 10.1007/s12439-014-0091-3  0.08
2010 Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, Monforte AD, Friis-Møller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. The Journal of Infectious Diseases. 201: 318-30. PMID 20039804 DOI: 10.1086/649897  0.08
2008 De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte Ad, Fontas E, Law MG, Friis-Møller N, Phillips A. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care. 31: 1224-9. PMID 18268071 DOI: 10.2337/dc07-2013  0.079
2013 Frentz D, Wensing AM, Albert J, Paraskevis D, Abecasis AB, Hamouda O, Jørgensen LB, Kücherer C, Struck D, Schmit JC, Ã…sjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, ... ... De Wit S, et al. Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology. 10: 36. PMID 23551870 DOI: 10.1186/1742-4690-10-36  0.078
2004 Fontas E, van Leth F, Sabin CA, Friis-Møller N, Rickenbach M, d'Arminio Monforte A, Kirk O, Dupon M, Morfeldt L, Mateu S, Petoumenos K, El-Sadr W, de Wit S, Lundgren JD, Pradier C, et al. Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? The Journal of Infectious Diseases. 189: 1056-74. PMID 14999610 DOI: 10.1086/381783  0.078
2015 Smit C, Arends J, Peters L, Montforte Ad, Dabis F, Zangerle R, Daikos G, Mussini C, Mallolas J, de Wit S, Zinkernagel A, Cosin J, Chene G, Raben D, et al. Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord. Bmc Infectious Diseases. 15: 498. PMID 26537918 DOI: 10.1186/S12879-015-1224-1  0.078
2004 d'Arminio A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O, El-Sadr W, De Wit S, Mateu S, Petoumenos K, Dabis F, Pradier C, Morfeldt L, Lundgren JD, Friis-Møller N, et al. Cardio- and cerebrovascular events in HIV-infected persons. Aids (London, England). 18: 1811-7. PMID 15316342 DOI: 10.1097/00002030-200409030-00010  0.078
2010 Vandenbroucke I, Van Marck H, Mostmans W, Van Eygen V, Rondelez E, Thys K, Van Baelen K, Fransen K, Vaira D, Kabeya K, De Wit S, Florence E, Moutschen M, Vandekerckhove L, Verhofstede C, et al. HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays. Aids Research and Therapy. 7: 4. PMID 20804564 DOI: 10.1186/1742-6405-7-4  0.078
2003 Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD, et al. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. Aids (London, England). 17: 1179-93. PMID 12819520 DOI: 10.1097/01.aids.0000060358.78202.c1  0.077
2009 Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation. 119: 805-11. PMID 19188509 DOI: 10.1161/Circulationaha.108.790857  0.077
2010 Lodwick R, Costagliola D, Reiss P, Torti C, Teira R, Dorrucci M, Ledergerber B, Mocroft A, Podzamczer D, Cozzi-Lepri A, Obel N, Masquelier B, Staszewski S, García F, ... De Wit S, et al. Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Archives of Internal Medicine. 170: 410-9. PMID 20212176 DOI: 10.1001/archinternmed.2009.472  0.074
2019 Tamminga M, de Wit S, Hiltermann TJN, Timens W, Schuuring E, Terstappen LWMM, Groen HJM. Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors. Journal For Immunotherapy of Cancer. 7: 173. PMID 31291995 DOI: 10.1186/s40425-019-0649-2  0.073
1998 De Wit S, Debier M, De Smet M, McCrea J, Stone J, Carides A, Matthews C, Deutsch P, Clumeck N. Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy. 42: 223-7. PMID 9527763  0.073
2012 Nkuize M, De Wit S, Muls V, Ntounda R, Gomez-Galdon M, Buset M. Comparison of demographic characteristics and upper gastrointestinal endoscopy findings in HIV-positive, antiretroviral-treated patients with and without Helicobacter pylori coinfection. Helicobacter. 17: 153-9. PMID 22404447 DOI: 10.1111/j.1523-5378.2011.00929.x  0.072
2010 Martin C, Neczyporenko F, De Wit S. A man with recurrent skin ulcerations. Acta Clinica Belgica. 65: 265-8. PMID 20954466 DOI: 10.1179/acb.2010.056  0.072
2018 de Wit S, Manicone M, Rossi E, Lampignano R, Yang L, Zill B, Rengel-Puertas A, Ouhlen M, Crespo M, Berghuis AMS, Andree KC, Vidotto R, Trapp EK, Tzschaschel M, Colomba E, et al. EpCAM and EpCAM circulating tumor cells in metastatic prostate and breast cancer patients. Oncotarget. 9: 35705-35716. PMID 30479699 DOI: 10.18632/oncotarget.26298  0.071
2010 Nkuize M, De Wit S, Muls V, Arvanitakis M, Buset M. Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy. Hiv Medicine. 11: 412-7. PMID 20146733 DOI: 10.1111/j.1468-1293.2009.00807.x  0.071
2011 Kamara DA, Worm SW, Reiss P, Rickenbach M, Phillips A, Kirk O, D'Arminio Monforte A, Bruyand M, Law M, De Wit S, Smith CJ, Pradier C, Lundgren J, Sabin C. The impact of fasting on the interpretation of triglyceride levels for predicting myocardial infarction risk in HIV-positive individuals: The D:A:D study Journal of Infectious Diseases. 204: 521-525. PMID 21791653 DOI: 10.1093/infdis/jir329  0.071
2010 Choppin E, De Wit S, Sosnowski M. Perioperative acute coronary syndrome during functional endoscopic sinus surgery in a young HIV-infected patient. A case report. Acta Anaesthesiologica Belgica. 61: 211-4. PMID 21388080  0.071
2008 Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1101-10. PMID 18461712 DOI: 10.1086/528862  0.07
2015 de Wit S, van Dalum G, Lenferink AT, Tibbe AG, Hiltermann TJ, Groen HJ, van Rijn CJ, Terstappen LW. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells. Scientific Reports. 5: 12270. PMID 26184843 DOI: 10.1038/srep12270  0.07
2005 Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, Gatell J, Clotet B, Phillips AN, Lundgren JD. Is there evidence for an increase in the death rate from liver-related disease in patients with HIV? Aids (London, England). 19: 2117-25. PMID 16284461  0.069
2021 Tanis CC, Leach NM, Geiger SJ, Nauta FH, Dablander F, van Harreveld F, de Wit S, Kanters G, Knoppers J, Markus DAW, Bouten RRM, Oostvogel QH, Boersma MJ, van der Steenhoven MV, Borsboom D, et al. Smart Distance Lab's art fair, experimental data on social distancing during the COVID-19 pandemic. Scientific Data. 8: 179. PMID 34267219 DOI: 10.1038/s41597-021-00971-2  0.069
2015 Eguavoen I, Schulz K, De Wit S, Weisser F, Müller-Mahn D. Political dimensions of climate change adaptation: Conceptual reflections and african examples Handbook of Climate Change Adaptation. 1183-1199. DOI: 10.1007/978-3-642-38670-1_55  0.069
1998 De Wit S, O'Doherty E, Edwards J, Yates R, Smith RP, Clumeck AN. Pharmacokinetics of two multiple-dosing regimens of D0870 in human immunodeficiency virus-positive patients: a phase I study. Antimicrobial Agents and Chemotherapy. 42: 903-6. PMID 9559805  0.069
2008 Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, Vetter N, Dabis F, Gatell J, Lundgren JD, Losso M, Duran A, Karpov I, Vassilenko A, Mitsura VM, ... ... De Wit S, et al. Loss to follow-up in an international, multicentre observational study Hiv Medicine. 9: 261-269. PMID 18400074 DOI: 10.1111/J.1468-1293.2008.00557.X  0.068
2012 Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends in Cognitive Sciences. 16: 81-91. PMID 22155014 DOI: 10.1016/J.Tics.2011.11.009  0.068
2010 Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte Ad, Flisiak R, Lundgren J. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. The Journal of Antimicrobial Chemotherapy. 65: 548-55. PMID 20051475 DOI: 10.1093/jac/dkp479  0.068
2014 de Wit S, van Dalum G, Terstappen LW. Detection of circulating tumor cells. Scientifica. 2014: 819362. PMID 25133014 DOI: 10.1155/2014/819362  0.068
2014 Van Beckhoven D, Lacor P, Moutschen M, Piérard D, Sasse A, Vaira D, Van den Wijngaert S, Vandercam B, Van Ranst M, Van Wijngaerden E, Vandekerckhove L, Verhofstede C, Verbrugge R, Demeester R, De Wit S, et al. Factors associated with the continuum of care of HIV-infected patients in Belgium. Journal of the International Aids Society. 17: 19534. PMID 25394043  0.068
2013 Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, d'Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, et al. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study. Bmc Infectious Diseases. 13: 471. PMID 24106926 DOI: 10.1186/1471-2334-13-471  0.067
2010 Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. Aids (London, England). 24: 1667-78. PMID 20523203 DOI: 10.1097/QAD.0b013e328339fe53  0.067
1993 De Wit S, Goossens H, Clumeck N. Single-dose versus 7 days of fluconazole treatment for oral candidiasis in human immunodeficiency virus-infected patients: a prospective, randomized pilot study. The Journal of Infectious Diseases. 168: 1332-3. PMID 8228378  0.067
2003 Derdelinckx I, Van Laethem K, Maes B, Schrooten Y, De Schouwer K, De Wit S, Fransen K, García Ribas S, Moutschen M, Vaira D, Zissis G, Van Ranst M, Van Wijngaerden E, Vandamme AM. Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes. Fems Immunology and Medical Microbiology. 39: 119-24. PMID 14625094  0.067
2014 Markowicz S, Delforge M, Necsoi C, De Wit S. Cardiovascular risk evaluation of HIV-positive patients in a case-control study: comparison of the D:A:D and Framingham equations. Journal of the International Aids Society. 17: 19515. PMID 25394024  0.066
1991 Bourdoux PP, De Wit SA, Servais GM, Clumeck N, Bonnyns MA. Biochemical thyroid profile in patients infected with the human immunodeficiency virus. Thyroid : Official Journal of the American Thyroid Association. 1: 147-9. PMID 1822360  0.066
2008 Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet. 371: 1417-26. PMID 18387667 DOI: 10.1016/S0140-6736(08)60423-7  0.066
2015 Friis-Møller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, De Wit S, Monforte AD, Kirk O, Fontas E, Sabin C, Phillips A, Lundgren J, Law M. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study. European Journal of Preventive Cardiology. PMID 25882821 DOI: 10.1177/2047487315579291  0.065
1989 De Wit S, Weerts D, Goossens H, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet. 1: 746-8. PMID 2564563 DOI: 10.1016/S0140-6736(89)92572-5  0.065
2009 Covens K, Kabeya K, Schrooten Y, Dekeersmaeker N, Van Wijngaerden E, Vandamme AM, De Wit S, Van Laethem K. Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 44: 325-8. PMID 19237313 DOI: 10.1016/j.jcv.2009.01.012  0.064
2023 Murugesu L, Damman OC, Timmermans DRM, de Wit S, Nieuwenhuijze M, Smets EMA, Fransen MP. Health literate-sensitive shared decision-making in maternity care: needs for support among maternity care professionals in the Netherlands. Bmc Pregnancy and Childbirth. 23: 594. PMID 37605153 DOI: 10.1186/s12884-023-05915-9  0.064
2015 Subirà M, Cano M, de Wit SJ, Alonso P, Cardoner N, Hoexter MQ, Kwon JS, Nakamae T, Lochner C, Sato JR, Jung WH, Narumoto J, Stein DJ, Pujol J, Mataix-Cols D, et al. Structural covariance of neostriatal and limbic regions in patients with obsessive-compulsive disorder. Journal of Psychiatry & Neuroscience : Jpn. 41: 150012. PMID 26505142 DOI: 10.1503/Jpn.150012  0.064
2011 Petoumenos K, Worm S, Reiss P, de Wit S, d'Arminio Monforte A, Sabin C, Friis-Møller N, Weber R, Mercie P, Pradier C, El-Sadr W, Kirk O, Lundgren J, Law M. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). Hiv Medicine. 12: 412-21. PMID 21251183 DOI: 10.1111/j.1468-1293.2010.00901.x  0.064
2009 Castaigne C, Tondeur M, de Wit S, Hildebrand M, Clumeck N, Dusart M. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nuclear Medicine Communications. 30: 41-7. PMID 19306513 DOI: 10.1097/MNM.0b013e328310b38d  0.064
2013 Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, ... ... De Wit S, et al. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 112-21. PMID 23532479 DOI: 10.1093/Cid/Cit196  0.064
2015 De Spiegelaere W, Philippé J, Vervisch K, Verhofstede C, Malatinkova E, Kiselinova M, Trypsteen W, Bonczkowski P, Vogelaers D, Callens S, Ruelle J, Kabeya K, De Wit S, Van Acker P, Van Sandt V, et al. Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care. Plos One. 10: e0123525. PMID 25874872 DOI: 10.1371/journal.pone.0123525  0.063
2022 Aboumsallem JP, Shi C, De Wit S, Markousis-Mavrogenis G, Bracun V, Eijgenraam TR, Hoes MF, Meijers WC, Screever EM, Schouten ME, Voors AA, Silljé HHW, De Boer RA. Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies. Journal of Molecular and Cellular Cardiology. 175: 13-28. PMID 36493852 DOI: 10.1016/j.yjmcc.2022.12.001  0.063
2013 Kovari H, Sabin CA, Ledergerber B, Ryom L, Worm SW, Smith C, Phillips A, Reiss P, Fontas E, Petoumenos K, De Wit S, Morlat P, Lundgren JD, Weber R. Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 870-9. PMID 23090925 DOI: 10.1093/cid/cis919  0.063
2011 Vandekerckhove L, Verhofstede C, Demecheleer E, De Wit S, Florence E, Fransen K, Moutschen M, Mostmans W, Kabeya K, Mackie N, Plum J, Vaira D, Van Baelen K, Vandenbroucke I, Van Eygen V, et al. Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment. The Journal of Antimicrobial Chemotherapy. 66: 265-72. PMID 21196489 DOI: 10.1093/jac/dkq458  0.063
2013 Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell JM, Mocroft A. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe. Hiv Medicine. 14: 503-8. PMID 23590641 DOI: 10.1111/hiv.12038  0.063
1999 De Wit S, Cassano P, Hermans P, Sommereijns B, Kabeya K, O'Doherty E, Clumeck N. Ritonavir-saquinavir rescue therapy in HIV-positive patients failing with indinavir, rotinavir or saquinavir. Aids (London, England). 13: 1794-5. PMID 10509591 DOI: 10.1097/00002030-199909100-00033  0.063
1988 De Wit S, Taelman H, Van de Perre P, Rouvroy D, Clumeck N. Salmonella bacteremia in African patients with human immunodeficiency virus infection. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 7: 45-7. PMID 3132375 DOI: 10.1007/BF01962170  0.062
2006 Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte Ad, Rickenbach M, Ledergerber B, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Archives of Internal Medicine. 166: 1632-41. PMID 16908797 DOI: 10.1001/archinte.166.15.1632  0.062
2014 Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, ... ... De Wit S, et al. Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1312-21. PMID 24457342 DOI: 10.1093/Cid/Ciu038  0.062
1997 Baily GG, Moore CB, Essayag SM, de Wit S, Burnie JP, Denning DW. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 161-3. PMID 9243058  0.062
2016 Konopnicki D, Manigart Y, Gilles C, Barlow P, DeMarchin J, Feoli F, Delforge M, Clumeck N, De Wit S. High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: Epidemiological implication for vaccination against human papillomavirus Aids. 30: 425-433. DOI: 10.1097/QAD.0000000000000929  0.062
2023 Shi C, de Wit S, Učambarlić E, Markousis-Mavrogenis G, Screever EM, Meijers WC, de Boer RA, Aboumsallem JP. Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms. Cancers. 15. PMID 36765688 DOI: 10.3390/cancers15030729  0.062
2011 Paredes R, Puertas MC, Bannister W, Kisic M, Cozzi-Lepri A, Pou C, Bellido R, Betancor G, Bogner J, Gargalianos P, Bánhegyi D, Clotet B, Lundgren J, Menéndez-Arias L, Martinez-Picado J, ... ... De Wit S, et al. A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy Journal of Infectious Diseases. 204: 741-752. PMID 21844300 DOI: 10.1093/infdis/jir385  0.062
1993 Dautzenberg B, Saint Marc T, Meyohas MC, Eliaszewitch M, Haniez F, Rogues AM, De Wit S, Cotte L, Chauvin JP, Grosset J. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Archives of Internal Medicine. 153: 368-72. PMID 8427539  0.061
2015 Podlekareva D, Grint D, Karpov I, Vassilenko A, Rakmanova A, Mansinho K, Chentsova N, Kravchenko E, Zeltina I, Losso M, Parczewski M, Lundgren J, Mocroft A, Kirk O, Kundro M, ... ... De Wit S, et al. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study Hiv Medicine. 16: 533-543. DOI: 10.1111/Hiv.12254  0.061
2008 Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, Katlama C, Martinez E, Nair D, Powderly WG, Reiss P, Sutinen J, Vigano A. European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. Hiv Medicine. 9: 72-81. PMID 18257770 DOI: 10.1111/j.1468-1293.2007.00534.x  0.061
1999 Hermans P, De Wit S, Sommereijns B, O'Doherty E, Clumeck N. Use of hydroxyurea in heavily pretreated patients with HIV infection. Antiviral Therapy. 4: 19-22. PMID 16021867  0.061
2007 Libois A, De Wit S, Poll B, Garcia F, Florence E, Del Rio A, Sanchez P, Negredo E, Vandenbruaene M, Gatell JM, Clumeck N. HIV and syphilis: when to perform a lumbar puncture. Sexually Transmitted Diseases. 34: 141-4. PMID 16865051 DOI: 10.1097/01.olq.0000230481.28936.e5  0.06
2015 van Velzen LS, de Wit SJ, Ćurĉić-Blake B, Cath DC, van Vries FE, Veltman DJ, van der Werf YD, van den Heuvel OA. Altered inhibition-related frontolimbic connectivity in obsessive-compulsive disorder Human Brain Mapping. DOI: 10.1002/hbm.22898  0.06
2003 Law M, Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Calvo G, El-Sadr W, De Wit S, Sabin CA, Lundgren JD. Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study. Hiv Medicine. 4: 1-10. PMID 12534953 DOI: 10.1046/J.1468-1293.2003.00138.X  0.06
2012 Bouchat S, Gatot JS, Kabeya K, Cardona C, Colin L, Herbein G, De Wit S, Clumeck N, Lambotte O, Rouzioux C, Rohr O, Van Lint C. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients. Aids (London, England). 26: 1473-82. PMID 22555163 DOI: 10.1097/QAD.0b013e32835535f5  0.059
2005 Van Laethem K, Schrooten Y, Lemey P, Van Wijngaerden E, De Wit S, Van Ranst M, Vandamme AM. A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene. Journal of Virological Methods. 123: 25-34. PMID 15582695 DOI: 10.1016/j.jviromet.2004.09.003  0.059
2015 Sasse A, Florence E, Pharris A, De Wit S, Lacor P, Van Beckhoven D, Deblonde J, Delforge ML, Fransen K, Goffard JC, Legrand JC, Moutschen M, Piérard D, Ruelle J, Vaira D, et al. Late presentation to HIV testing is overestimated when based on the consensus definition. Hiv Medicine. PMID 26222266 DOI: 10.1111/hiv.12292  0.059
2012 Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, ... ... De Wit S, et al. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. Plos Medicine. 9: e1001194. PMID 22448150 DOI: 10.1371/journal.pmed.1001194  0.059
2000 Clumeck N, De Wit S. Update on highly active antiretroviral therapy: progress and strategies. Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 54: 7-12. PMID 10721456  0.059
2014 Bollinger LA, Bogmans CWJ, Chappin EJL, Dijkema GPJ, Huibregtse JN, Maas N, Schenk T, Snelder M, van Thienen P, de Wit S, Wols B, Tavasszy LA. Climate adaptation of interconnected infrastructures: A framework for supporting governance Regional Environmental Change. 14: 919-931. DOI: 10.1007/s10113-013-0428-4  0.059
2023 Suthahar N, Wang D, Aboumsallem JP, Shi C, de Wit S, Liu EE, Lau ES, Bakker SJL, Gansevoort RT, van der Vegt B, Jovani M, Kreger BE, Lee Splansky G, Benjamin EJ, Vasan RS, et al. Association of Initial and Longitudinal Changes in C-reactive Protein With the Risk of Cardiovascular Disease, Cancer, and Mortality. Mayo Clinic Proceedings. 98: 549-558. PMID 37019514 DOI: 10.1016/j.mayocp.2022.10.013  0.058
2012 Payen MC, De Wit S, Martin C, Sergysels R, Muylle I, Van Laethem Y, Clumeck N. Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 16: 558-60. PMID 22325421 DOI: 10.5588/ijtld.11.0414  0.057
2015 Fan S, van den Heuvel OA, Cath DC, van der Werf YD, de Wit SJ, de Vries FE, Veltman DJ, Pouwels PJ. Mild White Matter Changes in Un-medicated Obsessive-Compulsive Disorder Patients and Their Unaffected Siblings. Frontiers in Neuroscience. 9: 495. PMID 26793045 DOI: 10.1016/J.Euroneuro.2016.07.014  0.057
1997 De Wit S, Dupont B, Cartledge JD, Hawkins DA, Gazzard BG, Clumeck N, Denning DW. A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis. Aids (London, England). 11: 759-63. PMID 9143608  0.057
2014 Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 384: 241-8. PMID 25042234 DOI: 10.1016/S0140-6736(14)60604-8  0.057
2010 Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet. 376: 340-5. PMID 20638118 DOI: 10.1016/S0140-6736(10)60932-4  0.057
2021 Bracun V, Suthahar N, Shi C, de Wit S, Meijers WC, Klip IT, de Boer RA, Aboumsallem JP. Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population. Frontiers in Cardiovascular Medicine. 8: 753885. PMID 34957244 DOI: 10.3389/fcvm.2021.753885  0.057
2001 Cherifi S, Hermans P, De Wit S, Cantinieaux B, Clumeck N. Acute pulmonary hypertension following paclitaxel in a patient with AIDS-related primary effusion lymphoma. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 7: 277-8. PMID 11422257  0.057
2005 Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD, Morfeldt L, Fontas E, Kirk O, De Wit S, Calvo G, Law MG, Dabis F, Sabin CA, Lundgren JD, et al. Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antiviral Therapy. 10: 811-23. PMID 16315369  0.057
2014 Nakagawa F, Lodwick R, Smith C, Costagliola D, Van Sighem A, Ledergerber B, Monforte ADA, Dorrucci M, Torti C, Suarez-Lozano I, Obel N, Brockmeyer N, Thiebaut R, Lundgren J, Castagna A, ... ... De Wit S, et al. Factors associated with short-term changes in HIV viral load and CD4+ cell count in antiretroviral-naive individuals Aids. 28: 1351-1356. DOI: 10.1097/QAD.0000000000000224  0.056
1988 Stanghelle JK, Winnem M, Roaldsen K, de Wit S, Notgewitch JH, Nilsen BR. Young patients with cystic fibrosis: attitude toward physical activity and influence on physical fitness and spirometric values of a 2-week training course. International Journal of Sports Medicine. 9: 25-31. PMID 3360540  0.056
2013 Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). Plos Medicine. 10: e1001510. PMID 24137103 DOI: 10.1371/Journal.Pmed.1001510  0.056
2020 Nanou A, Miller MC, Zeune LL, de Wit S, Punt CJA, Groen HJM, Hayes DF, de Bono JS, Terstappen LWMM. Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival. British Journal of Cancer. PMID 31937922 DOI: 10.1038/s41416-019-0726-9  0.055
2014 Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, de Wit S, Dabis F, Pradier C, Monforte Ad, Rickenbach M, Law M, Lundgren J, Sabin C. Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study. Journal of the International Aids Society. 17: 19516. PMID 25394025 DOI: 10.7448/Ias.17.4.19516  0.055
2010 Weber R, Sabin C, Reiss P, de Wit S, Worm SW, Law M, Dabis F, D'Arminio Monforte A, Fontas E, El-Sadr W, Kirk O, Rickenbach M, Phillips A, Ledergerber B, et al. HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study. Antiviral Therapy. 15: 1077-86. PMID 21149914 DOI: 10.3851/IMP1681  0.055
2013 Sabin CA, Ryom L, De Wit S, Mocroft A, Phillips AN, Worm SW, Weber R, D'Arminio Monforte A, Reiss P, Kamara D, El-Sadr W, Pradier C, Dabis F, Law M, Lundgren J, et al. Associations between immune depression and cardiovascular events in HIV infection. Aids (London, England). 27: 2735-48. PMID 23842128 DOI: 10.1097/01.aids.0000432457.91228.f3  0.055
1992 De Wit S, Hermans P, Sommereijns B, O'Doherty E, Westenborghs R, van de Velde V, Cauwenbergh GF, Clumeck N. Pharmacokinetics of R 82913 in AIDS patients: a phase I dose-finding study of oral administration compared with intravenous infusion. Antimicrobial Agents and Chemotherapy. 36: 2661-3. PMID 1482134  0.054
2013 Konopnicki D, Manigart Y, Gilles C, Barlow P, de Marchin J, Feoli F, Larsimont D, Delforge M, De Wit S, Clumeck N. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women. The Journal of Infectious Diseases. 207: 1723-9. PMID 23463709 DOI: 10.1093/infdis/jit090  0.054
2011 Kowalska JD, Friis-Møller N, Kirk O, Bannister W, Mocroft A, Sabin C, Reiss P, Gill J, Lewden C, Phillips A, D'Arminio Monforte A, Law M, Sterne J, De Wit S, Lundgren JD, et al. The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology (Cambridge, Mass.). 22: 516-23. PMID 21522013 DOI: 10.1097/EDE.0b013e31821b5332  0.054
1989 De Wit S, Clumeck N. Fluconazole in the treatment of fungal infections associated with AIDS. Infection. 17: 121-3. PMID 2544531  0.054
2013 Konopnicki D, Manigart Y, Gilles C, Barlow P, de Marchin J, Feoli F, Larsimont D, Delforge M, De Wit S, Clumeck N. High-risk human papillomavirus infection in HIV-positive African women living in Europe. Journal of the International Aids Society. 16: 18023. PMID 23406965 DOI: 10.7448/IAS.16.1.18023  0.054
2013 Wyndham-Thomas C, Delforge M, Mulkay JP, De Wit S. Barriers to liver transplantation in HIV infected patients. Acta Clinica Belgica. 68: 349-55. PMID 24579241 DOI: 10.2143/ACB.3249  0.053
2015 Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith CJ, d'Arminio Monforte A, Phillips A, Weber R, Lundgren J, Law MG. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. Hiv Medicine. PMID 26216031 DOI: 10.1111/hiv.12294  0.053
2011 Soriano V, Grint D, d'Arminio Monforte A, Horban A, Leen C, Poveda E, Antunes F, de Wit S, Lundgren J, Rockstroh J, Peters L. Hepatitis delta in HIV-infected individuals in Europe. Aids (London, England). 25: 1987-92. PMID 21857493 DOI: 10.1097/QAD.0b013e32834babb3  0.053
2015 Méric de Bellefon L, Épée H, Langhendries JP, De Wit S, Corazza F, Di Romana S. Increase in the prevalence of anti-cyclic citrullinated peptide antibodies in the serum of 185 patients infected with Human Immunodeficiency Virus. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 26454508 DOI: 10.1016/j.jbspin.2015.08.014  0.053
2010 Mocroft A, Reiss P, Kirk O, Mussini C, Girardi E, Morlat P, Stephan C, De Wit S, Doerholt K, Ghosn J, Bucher HC, Lundgren JD, Chene G, Miro JM, et al. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 51: 611-9. PMID 20645862 DOI: 10.1086/655761  0.052
2015 Grint D, Peters L, Rockstroh JK, Rakmanova A, Trofimova T, Lacombe K, Karpov I, Galli M, Domingo P, Kirk O, Lundgren JD, Mocrofta A, Losso M, Kundro M, Vetter N, ... ... De Wit S, et al. Liver-related death among HIV/hepatitis C virus-co-infected individuals: Implications for the era of directly acting antivirals Aids. 29: 1205-1215. DOI: 10.1097/QAD.0000000000000674  0.052
1986 Newman NM, Donaldson S, de Wit S, King O, Wilbur JR. Neuro-ocular damage in pediatric oncology patients: predictor of long-term visual disability or tool for limiting toxicity? Medical and Pediatric Oncology. 14: 262-70. PMID 3784980  0.051
2008 Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. Aids (London, England). 22: 2143-53. PMID 18832878 DOI: 10.1097/QAD.0b013e3283112b77  0.051
2014 Mocroft A, Ryom L, Reiss P, Furrer H, D'Arminio Monforte A, Gatell J, de Wit S, Beniowski M, Lundgren JD, Kirk O. A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection. Hiv Medicine. 15: 144-52. PMID 24118916 DOI: 10.1111/hiv.12095  0.05
2014 Grint D, Peters L, Rockstroh JK, de Wit S, Mitsura VM, Knysz B, Pedersen C, Kirk O, Lundgren JD, Mocroft A. Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis. Aids (London, England). 28: 577-87. PMID 24468998 DOI: 10.1097/QAD.0000000000000069  0.05
2022 Shi C, Aboumsallem JP, Suthahar N, de Graaf AO, Jansen JH, van Zeventer IA, Bracun V, de Wit S, Screever EM, van den Berg PF, Meijers WC, Gansevoort RT, Bakker SJL, van der Harst P, Silljé HHW, et al. Clonal hematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers. European Journal of Heart Failure. PMID 36221810 DOI: 10.1002/ejhf.2715  0.05
2014 Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin CA, El-Sadr W, d'Arminio Monforte A, Phillips AN, De Wit S, Kirk O, Dabis F, Pradier C, Lundgren JD, Law MG. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. Hiv Medicine. 15: 595-603. PMID 24840675 DOI: 10.1111/hiv.12162  0.05
2013 Monforte Ad, Reiss P, Ryom L, El-Sadr W, Dabis F, De Wit S, Worm SW, Law MG, Weber R, Kirk O, Pradier C, Phillips AN, Lundgren JD, Sabin CA. Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events. Aids (London, England). 27: 407-15. PMID 23291539 DOI: 10.1097/QAD.0b013e32835b2ef1  0.049
2007 Block H, Meyer-Block K, Rebeski DE, Scharr H, de Wit S, Rohn K, Rautenschlein S. A field study on the significance of vaccination against infectious bursal disease virus (IBDV) at the optimal time point in broiler flocks with maternally derived IBDV antibodies. Avian Pathology : Journal of the W.V.P.A. 36: 401-9. PMID 17899465 DOI: 10.1080/03079450701589175  0.049
1999 De Wit S, Cassano P, Hermans P, Kabeya K, Gerard M, O'Doherty E, Clumeck N. Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine. Aids (London, England). 13: 864-5. PMID 10357390 DOI: 10.1097/00002030-199905070-00020  0.049
2012 Smit C, Sterne JAC, Monforte ADA, Puotti M, De Wolf F, Peters L, Ledergerber B, De Wit S, Sambatakou H, Rauch A, Dabis F. Effect of hepatitis C treatment on CD4+ T-cell counts and the risk of death in HIV-HCV-coinfected patients: The COHERE collaboration Antiviral Therapy. 17: 1541-1550. PMID 22869294 DOI: 10.3851/Imp2263  0.048
2008 Calmy A, Carey D, Mallon PWG, Wand H, Law M, Cooper DA, Carr A, Yeni P, Aboulker JP, Antunes F, Babiker A, Becker M, Boukli N, Brun-Vezinet F, Churchill D, ... ... De Wit S, et al. Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy Hiv Medicine. 9: 101-110. PMID 18257772 DOI: 10.1111/j.1468-1293.2007.00527.x  0.048
2010 Libois A, Clumeck N, Kabeya K, Gerard M, De Wit S, Poll B, Tondeur M, Rozenberg S. Risk factors of osteopenia in HIV-infected women: no role of antiretroviral therapy. Maturitas. 65: 51-4. PMID 19939594 DOI: 10.1016/j.maturitas.2009.10.009  0.048
2013 Costagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touloumi G, et al. Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes. The Journal of Infectious Diseases. 207: 759-67. PMID 23225900 DOI: 10.1093/Infdis/Jis752  0.046
2013 Martin C, Castaigne C, Tondeur M, Flamen P, De Wit S. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study. Hiv Medicine. 14: 455-62. PMID 23517190 DOI: 10.1111/hiv.12030  0.046
1996 Revets H, Marissens D, de Wit S, Lacor P, Clumeck N, Lauwers S, Zissis G. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. Journal of Clinical Microbiology. 34: 1058-64. PMID 8727875  0.046
2012 Bisgaard M, Nørskov-Lauritsen N, de Wit SJ, Hess C, Christensen H. Multilocus sequence phylogenetic analysis of Avibacterium. Microbiology (Reading, England). 158: 993-1004. PMID 22241047 DOI: 10.1099/mic.0.054429-0  0.046
2010 Covens K, Megens S, Dekeersmaeker N, Kabeya K, Balzarini J, De Wit S, Vandamme AM, Van Laethem K. The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirtide resistance levels of common enfuvirtide resistance mutations that did not impact susceptibility to sifuvirtide. Antiviral Research. 86: 253-60. PMID 20227441 DOI: 10.1016/j.antiviral.2010.03.003  0.045
2018 de Wit S, Zeune LL, Hiltermann TJN, Groen HJM, Dalum GV, Terstappen LWMM. Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis. Cancers. 10. PMID 30308977 DOI: 10.3390/cancers10100377  0.045
2022 Bracun V, van Essen B, Voors AA, van Veldhuisen DJ, Dickstein K, Zannad F, Metra M, Anker S, Samani NJ, Ponikowski P, Filippatos G, Cleland JGF, Lang CC, Ng LL, Shi C, ... de Wit S, et al. Insulin-like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence. Esc Heart Failure. PMID 36088651 DOI: 10.1002/ehf2.14120  0.045
2022 de Wit S, Glen C, de Boer RA, Lang NN. Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies. Cardiovascular Research. PMID 36004495 DOI: 10.1093/cvr/cvac132  0.045
2015 Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, et al. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. The Lancet. Hiv. 2: e464-73. PMID 26520926 DOI: 10.1016/S2352-3018(15)00181-2  0.045
2016 Bouchat S, Delacourt N, Kula A, Darcis G, Van Driessche B, Corazza F, Gatot JS, Melard A, Vanhulle C, Kabeya K, Pardons M, Avettand-Fenoel V, Clumeck N, De Wit S, Rohr O, et al. Sequential treatment with 5-aza-2′-deoxycytidine and deacetylase inhibitors reactivates HIV-1 Embo Molecular Medicine. 8: 117-138. DOI: 10.15252/emmm.201505557  0.044
2007 Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD. Class of antiretroviral drugs and the risk of myocardial infarction. The New England Journal of Medicine. 356: 1723-35. PMID 17460226 DOI: 10.1056/NEJMoa062744  0.044
1997 Payen MC, De Wit S, Clumeck N. [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. Revue Des Maladies Respiratoires. 14: S142-51. PMID 9496599  0.044
2012 Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A, Jansen K, Masquelier B, García F, ... De Wit S, et al. Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe. Journal of Acquired Immune Deficiency Syndromes (1999). 59: 294-9. PMID 22083070 DOI: 10.1097/QAI.0b013e31823fe66b  0.044
2005 Konopnicki D, De Wit S, Poll B, Crommentuyn K, Huitema A, Clumeck N. Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice daily. Hiv Medicine. 6: 1-6. PMID 15670245 DOI: 10.1111/j.1468-1293.2005.00255.x  0.044
2000 Ieven M, Goossens W, De Wit S, Goossens H. In vitro activity of gemifloxacin compared with other antimicrobial agents against recent clinical isolates of streptococci. The Journal of Antimicrobial Chemotherapy. 45: 51-3. PMID 10824033  0.044
2014 Mocroft A, Reiss P, Rakhmanova A, Banhegyi D, Phillips AN, De Wit S, Ristola M, Lundgren JD, Grarup J, Kirk O. A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe. Infection. 42: 757-62. PMID 24902520 DOI: 10.1007/s15010-014-0630-4  0.044
2015 Méric De Bellefon L, Épée H, Langhendries JP, De Wit S, Corazza F, Di Romana S. Increase in the prevalence of anti-cyclic citrullinated peptide antibodies in the serum of 185 patients infected with human immunodeficiency virus | Augmentation de la prévalence des anticorps anti-peptides cycliques citrullinés dans le sérum de 185 patients infectés par le virus de l'immunodéficience humaine Revue Du Rhumatisme (Edition Francaise). 82: 140-141.  0.043
2016 Ryom L, Lundgren JD, de Wit S, Kovari H, Reiss P, Law M, El-Sadr W, Monforte AD, Mocroft A, Smith C, Fontas E, Dabis F, Phillips A, Sabin C. Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons Aids. DOI: 10.1097/QAD.0000000000001018  0.043
2016 Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, Furrer H, Miro JM, Gatell JM, Pozniak A, Behrens G, Battegay M, Lundgren JD, Monforte AdA, Arribas J, ... ... De Wit S, et al. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons Hiv Medicine. 17: 83-88. DOI: 10.1111/hiv.12322  0.043
1999 De Wit S, Cremers L, Hirsch D, Zulian C, Clumeck N, Kormoss N. Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study. The Journal of International Medical Research. 27: 223-32. PMID 10689628  0.043
1979 Konings AW, de Wit SS, Lamberts HB. Initial events in radiation-induced atheromatosis. III. Effect on lipase activity. Strahlentherapie. 155: 655-7. PMID 505473  0.042
2012 Worm SW, Kamara DA, Reiss P, Fontas E, De Wit S, El-Sadr W, D'Arminio Monforte A, Law M, Phillips A, Ryom L, Dabis F, Weber R, Sabin C, Lundgren JD. Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke. The Journal of Infectious Diseases. 205: 535-9. PMID 22223855 DOI: 10.1093/infdis/jir788  0.042
1996 Katlama C, De Wit S, O'Doherty E, Van Glabeke M, Clumeck N. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 22: 268-75. PMID 8838183  0.042
2018 Aalbers G, McNally RJ, Heeren A, de Wit S, Fried EI. Social media and depression symptoms: A network perspective. Journal of Experimental Psychology. General. PMID 30507215 DOI: 10.1037/Xge0000528  0.042
1996 De Wit S, Flausch A. [Screening for notification of seropositivity: ethical and psychological aspects]. Revue Mã©Dicale De Bruxelles. 17: 167-70. PMID 8927839  0.042
2005 De Wit S. [Treatment for HIV infection: 2005 recommendations]. Revue Mã©Dicale De Bruxelles. 26: S378-81. PMID 16240890  0.042
2015 Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C. Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 568-77. PMID 25763785 DOI: 10.1097/QAI.0000000000000523  0.042
2015 Rive MM, Mocking RJ, Koeter MW, van Wingen G, de Wit SJ, van den Heuvel OA, Veltman DJ, Ruhé HG, Schene AH. State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder. Jama Psychiatry. 72: 687-96. PMID 25945779 DOI: 10.1001/Jamapsychiatry.2015.0161  0.041
2023 van den Berg PF, Aboumsallem JP, Screever EM, Shi C, de Wit S, Bracun V, Yousif LI, Geerlings L, Wang D, Ho JE, Bakker SJL, van der Vegt B, Silljé HHW, de Boer RA, Meijers WC. Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure. Jacc. Cardiooncology. 5: 445-453. PMID 37614579 DOI: 10.1016/j.jaccao.2023.03.015  0.041
1998 Cartledge JD, Denning DW, Dupont B, Clumeck N, De Wit S, Midgley J, Hawkins DA, Gazzard BG. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal. Aids (London, England). 12: 411-6. PMID 9520171  0.041
2002 Dibbets P, Maes JHR, Van Den Berg P, De Wit S, Vossen JMH. Feature positive discriminations in adults and children Cognitive Development. 17: 1235-1248. DOI: 10.1016/S0885-2014(02)00115-6  0.041
2009 Loutfy M, Ribera E, Florence E, De Wit S, Castagna A, Ryan R, Hill A, Vanaken H, van Delft Y, Marks S. Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme. The Journal of Antimicrobial Chemotherapy. 64: 1341-4. PMID 19828488 DOI: 10.1093/jac/dkp366  0.041
1999 Postelmans L, Payen MC, De Wit S, Caspers-Velu L. Neovascularization of the optic disc after highly active antiretroviral therapy in an AIDS patient with cytomegalovirus retinitis--A new immune recovery-related ocular disorder? Ocular Immunology and Inflammation. 7: 237-40. PMID 10611733  0.04
2015 de Wit SJ, van der Werf YD, Mataix-Cols D, Trujillo JP, van Oppen P, Veltman DJ, van den Heuvel OA. Emotion regulation before and after transcranial magnetic stimulation in obsessive compulsive disorder. Psychological Medicine. 45: 3059-73. PMID 26027740 DOI: 10.1017/S0033291715001026  0.04
2003 Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD, et al. Combination antiretroviral therapy and the risk of myocardial infarction. The New England Journal of Medicine. 349: 1993-2003. PMID 14627784 DOI: 10.1056/Nejmoa030218  0.039
1988 Clumeck N, Hermans P, De Wit S. Current problems in the management of AIDS patients. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 7: 2-10. PMID 2837391  0.039
2013 Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, ... ... de Wit S, et al. The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1038-47. PMID 23921881 DOI: 10.1093/cid/cit423  0.039
2021 de Wit S, de Boer RA. From Studying Heart Disease and Cancer Simultaneously to Reverse Cardio-Oncology. Circulation. 144: 93-95. PMID 34251889 DOI: 10.1161/CIRCULATIONAHA.120.053315  0.038
2000 De Wit S. Commentary on the summary of the French Guidelines for the treatment of HIV-infected adults with antiretroviral therapy. Hiv Medicine. 1: 132. PMID 11737338  0.038
2014 Shepherd L, Borges AH, Ravn L, Harvey R, Jean-Paul V, Bower M, Grulich A, Silverberg M, De Wit S, Kirk O, Lundgren J, Mocroft A. Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA. Journal of the International Aids Society. 17: 19510. PMID 25394019  0.037
2015 Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J, Kenyon C, Florence E, Buvé A. Risk factors for HCV acquisition among HIV-positive MSM in Belgium. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 585-93. PMID 25763786 DOI: 10.1097/QAI.0000000000000528  0.037
2013 van Heurck R, Payen MC, De Wit S, Clumeck N. Epidemiology of MDR-TB in a Belgian infectious diseases unit: a 15 years review. Acta Clinica Belgica. 68: 321-4. PMID 24579238 DOI: 10.2143/ACB.3269  0.037
1999 De Wit S, Sternon J, Clumeck N. [Nevirapine (Viramune): a new HIV inhibitor]. Revue Mã©Dicale De Bruxelles. 20: 95-9. PMID 10335104  0.036
1991 De Wit S, Urbain D, Rahir F, Weerts D, Clumeck N. Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 10: 503-5. PMID 1915385  0.036
2011 Worm SW, Kamara DA, Reiss P, Kirk O, El-Sadr W, Fux C, Fontas E, Phillips A, D'Arminio Monforte A, De Wit S, Petoumenos K, Friis-Mller N, Mercie P, Lundgren JD, Sabin C. Elevated triglycerides and risk of myocardial infarction in HIV-positive persons. Aids (London, England). 25: 1497-504. PMID 21633288 DOI: 10.1097/QAD.0b013e32834917c6  0.036
2010 Jansen CA, van de Haar PM, van Haarlem D, van Kooten P, de Wit S, van Eden W, Viertlböck BC, Göbel TW, Vervelde L. Identification of new populations of chicken natural killer (NK) cells. Developmental and Comparative Immunology. 34: 759-67. PMID 20188123 DOI: 10.1016/j.dci.2010.02.009  0.036
2013 de Wit S, Donohue PK, Shepard J, Boss RD. Mother-clinician discussions in the neonatal intensive care unit: agree to disagree? Journal of Perinatology : Official Journal of the California Perinatal Association. 33: 278-81. PMID 22899183 DOI: 10.1038/jp.2012.103  0.035
1988 de Wit S, Van Laethem Y, Clumeck N. [Pulmonary manifestations of acquired immunodeficiency syndrome]. Revue Des Maladies Respiratoires. 5: 551-64. PMID 3064202  0.034
2011 Verhofstede C, Brudney D, Reynaerts J, Vaira D, Fransen K, De Bel A, Seguin-Devaux C, De Wit S, Vandekerckhove L, Geretti AM. Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA. Hiv Medicine. 12: 544-52. PMID 21518222 DOI: 10.1111/j.1468-1293.2011.00922.x  0.034
2014 De Wit S. Green galaxies; An interstitial strategy for restorative spaces New Urban Configurations. 930-935. DOI: 10.3233/978-1-61499-365-0-935  0.034
2010 Florence E, De Wit S, Castagna A, Ribera E, Hill A, Vanaken H, van Delft Y, Marks S. HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme. International Journal of Std & Aids. 21: 224-5. PMID 20071441 DOI: 10.1258/ijsa.2009.009425  0.033
2015 Nkuize M, De Wit S, Muls V, Delforge M, Deyi VYM, Cadière GB, Buset M. HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors Plos One. 10. DOI: 10.1371/journal.pone.0145119  0.032
1986 De Maubeuge J, Ledoux M, Feremans W, Zissis G, Goens J, Andre J, Gourdain JM, Menu R, De Wit S, Cran S. Oral "hairy" leucoplakia in an African AIDS patient. Journal of Cutaneous Pathology. 13: 235-41. PMID 3734224  0.032
1994 Cadiere GB, Verroken R, Himpens J, Bruyns J, Efira M, De Wit S. Operative strategy in laparoscopic splenectomy. Journal of the American College of Surgeons. 179: 668-72. PMID 7952479  0.032
1989 Clumeck N, Taelman H, Hermans P, Piot P, Schoumacher M, De Wit S. A cluster of HIV infection among heterosexual people without apparent risk factors. The New England Journal of Medicine. 321: 1460-2. PMID 2811959 DOI: 10.1056/NEJM198911233212107  0.032
2015 Casadellá M, van Ham PM, Noguera-Julian M, van Kessel A, Pou C, Hofstra LM, Santos JR, Garcia F, Struck D, Alexiev I, Bakken Kran AM, Hoepelman AI, Kostrikis LG, Somogyi S, Liitsola K, ... ... De Wit S, et al. Primary resistance to integrase strand-transfer inhibitors in Europe Journal of Antimicrobial Chemotherapy. 70: 2885-2888. DOI: 10.1093/jac/dkv202  0.032
2013 Konopnicki D, De Wit S, Clumeck N. HPV and HIV coinfection: A complex interaction resulting in epidemiological, clinical and therapeutic implications Future Virology. 8: 903-915. DOI: 10.2217/fvl.13.69  0.031
2001 Moore E, O'Flaherty D, Heuvelmans H, Seaman J, Veeken H, de Wit S, Davidson RN. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya. Bulletin of the World Health Organization. 79: 388-93. PMID 11417033  0.031
2004 Snoeck J, Van Laethem K, Hermans P, Van Wijngaerden E, Derdelinckx I, Schrooten Y, van de Vijver DA, De Wit S, Clumeck N, Vandamme AM. Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. Journal of Acquired Immune Deficiency Syndromes (1999). 35: 279-85. PMID 15076243  0.031
2014 Parker D, de Wit S, Houghton H, Prandini F. Assessment of impact of a novel infectious bursal disease (IBD) vaccination programme in breeders on IBD humoral antibody levels through the laying period. Veterinary Record Open. 1: e000016. PMID 26392872 DOI: 10.1136/vropen-2013-000016  0.03
1993 De Wit S, D'Abbraccio M, De Mol P, Clumeck N, D'Abraccio M. Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection. Lancet. 341: 53-4. PMID 8093299  0.029
2014 de Wit S. Challenges in public and private domains will shape the future of intellectual property Ntut Journal of Intellectual Property Law and Management. 3: 21-33.  0.029
2015 Van Beckhoven D, Florence E, Ruelle J, Deblonde J, Verhofstede C, Callens S, Vancutsem E, Lacor P, Demeester R, Goffard JC, Sasse A, De Wit S, Vogelaers D, Delforge ML, Fransen K, et al. Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants Bmc Infectious Diseases. 15. DOI: 10.1186/s12879-015-1230-3  0.029
1999 Colebunders R, Clumeck N, Florence E, Vandercam B, Van Wanzeele F, Van Wijngaerden E, Lacor P, Demonty J, De Wit S. Safe and effective use of combination antiretroviral treatment. Acta Clinica Belgica. 54: 55-60. PMID 10394641 DOI: 10.1080/17843286.1999.11754209  0.029
2023 Shi C, Zijlstra SN, de Wit S, Meijers WC, Aboumsallem JP, Silljé HHW, de Boer RA. Divergent effects of myostatin inhibition on cardiac and skeletal muscles in a mouse model of pressure overload. American Journal of Physiology. Heart and Circulatory Physiology. 325: H195-H201. PMID 37294894 DOI: 10.1152/ajpheart.00223.2023  0.028
2010 Moodley A, Oosthuysen WF, Dusé AG, Marais E, Dusé A, Brink A, Coetzee G, Mogale J, Mahlati S, Badenhorts L, Fick K, Botha E, Jordaan C, Janse Van Rensburg MN, Botha M, ... ... De Wit S, et al. Molecular Characterization of Clinical Methicillin-Resistant Staphylococcus aureus Isolates in South Africa Journal of Clinical Microbiology. 48: 4608-4611. PMID 20881169 DOI: 10.1128/JCM.01704-10  0.028
2019 Tamminga M, de Wit S, Van De Wauwer C, van den Bos H, Swennenhuis JF, Klinkenberg TJ, Hiltermann TJN, Andree KC, Spierings DCJ, Lansdorp PM, van den Berg A, Timens W, Terstappen LW, Groen HJ. Release of circulating tumor cells during surgery for non-small cell lung cancer: are they what they appear to be? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31772122 DOI: 10.1158/1078-0432.CCR-19-2541  0.027
1978 Konings AW, Smit Sibinga CT, Aarnoudse MW, de Wit SS, Lamberts HB. Initial events in radiation-induced atheromatosis. II. Damage to intimal cells. Strahlentherapie. 154: 795-800. PMID 715813  0.026
1987 Van de Perre P, Clumeck N, Steens M, Zissis G, Caraël M, Lagasse R, De Wit S, Lafontaine T, De Mol P, Butzler JP. Seroepidemiological study on sexually transmitted diseases and hepatitis B in African promiscuous heterosexuals in relation to HTLV-III infection. European Journal of Epidemiology. 3: 14-8. PMID 3556210  0.026
2000 De Wit S. [7th Conference on Retroviruses and Opportunistic Infections]. Revue Mã©Dicale De Bruxelles. 21: A521-3. PMID 11194504  0.025
2013 Gonzales JL, Stegeman JA, Koch G, de Wit SJ, Elbers AR. Rate of introduction of a low pathogenic avian influenza virus infection in different poultry production sectors in the Netherlands. Influenza and Other Respiratory Viruses. 7: 6-10. PMID 22376126 DOI: 10.1111/j.1750-2659.2012.00348.x  0.025
2016 Huibregtse E, Napoles OM, Hellebrandt L, Paprotny D, de Wit S. Climate change in asset management of infrastructure: A risk-based methodology applied to disruption of traffic on road networks due to the flooding of tunnels European Journal of Transport and Infrastructure Research. 16: 98-113.  0.024
2021 Shi C, Aboumsallem JP, de Wit S, Schouten EM, Bracun V, Meijers WC, Silljé HHW, de Boer RA. Evaluation of renal cancer progression in a mouse model of heart failure. Cancer Communications (London, England). PMID 34240830 DOI: 10.1002/cac2.12185  0.023
2023 Brinkhof LP, Huth KBS, Murre JMJ, de Wit S, Krugers HJ, Ridderinkhof KR. Corrigendum: The interplay between quality of life and resilience factors in later life: a network analysis. Frontiers in Psychology. 14: 1264753. PMID 37614492 DOI: 10.3389/fpsyg.2023.1264753  0.022
1998 De Wit S, O'Doherty E, De Vroey C, Clumeck N. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis. The Journal of International Medical Research. 26: 159-70. PMID 9718471  0.021
1994 de Wit S, Cleton FJ. Hypercalcemia in patients with breast cancer: a survival study. Journal of Cancer Research and Clinical Oncology. 120: 610-4. PMID 7929533  0.021
1988 Van Laethem Y, Hermans P, De Wit S, Goosens H, Clumeck N. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results. The Journal of Antimicrobial Chemotherapy. 21: 81-7. PMID 2965135  0.021
1984 Kains JP, De Wit S, Dourov N, Petre JJ, Paulet P. [Thorotrastosis, fossil pathology]. Acta Gastro-Enterologica Belgica. 47: 23-7. PMID 6741403  0.02
1995 Snoeck R, Van Ranst M, Andrei G, De Clercq E, De Wit S, Poncin M, Clumeck N. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue. The New England Journal of Medicine. 333: 943-4. PMID 7666893 DOI: 10.1056/NEJM199510053331418  0.019
1982 Paulet P, De Wit S, Kains JP, Robert J, Petre JJ. [Paralytic ileus due to vinblastine. Case report and review of the literature]. Acta Gastro-Enterologica Belgica. 45: 413-9. PMID 6191509  0.019
2013 Dobbels L, Touma D, Ntounda R, De Wit S. Gastric Kaposi's sarcoma and vomiting in a 21-year-old female | Kaposi-maagsarcoom en braken bij een 21-jarige vrouw Tijdschrift Voor Geneeskunde. 69: 399-401. DOI: 10.2143/TVG.69.08.2001376  0.018
2009 van der Velde R, de Wit S. The landscape form of the metropolis Footprint. 55-79.  0.015
2015 Dauby N, Coussement J, Karakike E, Ungureanu C, De Wit S, Payen MC. Acute myocardial infarction following thalidomide treatment for AIDS-related ulcers. Aids (London, England). 29: 1119-20. PMID 26125145 DOI: 10.1097/QAD.0000000000000656  0.015
2018 de Wit S, Rossi E, Weber S, Tamminga M, Manicone M, Swennenhuis JF, Groothuis-Oudshoorn CGM, Vidotto R, Facchinetti A, Zeune LL, Schuuring E, Zamarchi R, Hiltermann TJN, Speicher MR, Heitzer E, et al. Single tube liquid biopsy for advanced non-small cell lung cancer. International Journal of Cancer. PMID 30536653 DOI: 10.1002/ijc.32056  0.015
2015 de Wit S. Global warning: An ethnography of the encounter between global and local climate-change discourses in the Bamenda grassfields, Cameroon Global Warning: An Ethnography of the Encounter Between Global and Local Climate-Change Discourses in the Bamenda Grassfields, Cameroon. 1-239.  0.014
1991 Hermans P, Gerard M, van Laethem Y, de Wit S, Clumeck N. Pancreatic disturbances and typhoid fever. Scandinavian Journal of Infectious Diseases. 23: 201-5. PMID 1712981  0.013
2016 De Wit SI. Let's Walk Urban Landscapes. New Pathways in Design Research Journal of Landscape Architecture. 11: 96-97. DOI: 10.1080/18626033.2016.1144695  0.013
1987 Clumeck N, Hermans P, De Wit S. Some epidemiological and clinical characteristics of African AIDS. Antibiotics and Chemotherapy. 38: 41-51. PMID 3310863  0.012
2008 De Wit S, Audenaert K. ADHD in adults with co-morbid stimulant abuse disorder: Diagnosis and treatment | ADHD bij volwassenen bij gebruik van stimulantia: Comorbide stoornissen. Diagnostiek en behandeling Tijdschrift Voor Geneeskunde. 64: 570-577. DOI: 10.2143/TVG.64.11.2000330  0.011
2023 de Wit S, Aboumsallem JP, Shi C, Schouten EM, Bracun V, Meijers WC, Silljé HHW, de Boer RA. Pressure Overload-Induced Cardiac Hypertrophy Stimulates Tumor Growth in Tumor-Prone Apc Mice. Circulation. Heart Failure. e010740. PMID 37609881 DOI: 10.1161/CIRCHEARTFAILURE.123.010740  0.01
2014 Bouman B, Woestijne J, De Wit S, De Koster N. MCC for SIL-rated applications 11th Petroleum and Chemical Industry Conference Europe Electrical and Instrumentation Applications, Pcic 2014. DOI: 10.1109/PCICEurope.2014.6900064  0.01
1997 Swan JH, Harrington C, de Wit SK, Zhong M. State-imposed limits on Medicaid reimbursement for nursing facility care. American Journal of Public Health. 87: 1211-3. PMID 9240116  0.01
1990 Hermans P, Gerard M, De Wit S, Van Laethem Y. Pancreatitis and typhoid fever. The American Journal of Medicine. 89: 546-7. PMID 2220896  0.01
1989 De Wit S, Clumeck N. [Heterosexual transmission of AIDS]. Revue Mã©Dicale De Bruxelles. 10: 336-9. PMID 2814084  0.01
1986 Goossens H, Ghysels G, Van Laethem Y, De Wit S, Levy J, De Mol P, Clumeck N, Butzler JP, Wenzel RP. Predicting gentamicin resistance from annual usage in hospital. Lancet. 2: 804-5. PMID 2876248 DOI: 10.1016/S0140-6736(86)90316-8  0.01
1985 Jakubowski M, Lamont A, Murray WB, de Wit SL. Anaesthesia for microsurgery. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 67: 581-4. PMID 3983738  0.01
1984 Pegelow CH, Popper RW, de Wit SA, King OY, Wilbur JR. Endomyocardial biopsy to monitor anthracycline therapy in children. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2: 443-6. PMID 6587017  0.01
1983 Kains JP, De Wit S, Close P, Melot C, Nagler J, Van Rooy P. Exertional heat stress disease. Acta Clinica Belgica. 38: 315-23. PMID 6659838  0.01
Hide low-probability matches.